669 related articles for article (PubMed ID: 28739486)
1. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway.
Chen Y; Wu Z; Yuan B; Dong Y; Zhang L; Zeng Z
Cell Death Dis; 2018 Jan; 9(2):22. PubMed ID: 29348414
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis.
Tao L; Xue D; Shen D; Ma W; Zhang J; Wang X; Zhang W; Wu L; Pan K; Yang Y; Nwosu ZC; Dooley S; Seki E; Liu C
Arch Toxicol; 2018 Sep; 92(9):2935-2946. PubMed ID: 30097701
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
He Y; Huang C; Sun X; Long XR; Lv XW; Li J
Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis.
Ge YT; Zhong AQ; Xu GF; Lu Y
Immunopharmacol Immunotoxicol; 2019 Oct; 41(5):549-557. PubMed ID: 31530042
[No Abstract] [Full Text] [Related]
8. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling.
Yuan BY; Chen YH; Wu ZF; Zhuang Y; Chen GW; Zhang L; Zhang HG; Cheng JC; Lin Q; Zeng ZC
Radiat Res; 2019 Dec; 192(6):621-629. PubMed ID: 31560641
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.
Liu C; Chen X; Yang L; Kisseleva T; Brenner DA; Seki E
J Biol Chem; 2014 Mar; 289(10):7082-7091. PubMed ID: 24448807
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
14. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
15. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146b-5p Suppresses Pro-Inflammatory Mediator Synthesis via Targeting TRAF6, IRAK1, and RELA in Lipopolysaccharide-Stimulated Human Dental Pulp Cells.
Han P; Sunada-Nara K; Kawashima N; Fujii M; Wang S; Kieu TQ; Yu Z; Okiji T
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108595
[TBL] [Abstract][Full Text] [Related]
18. MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes.
Zou Y; Li S; Li Z; Song D; Zhang S; Yao Q
Cell Signal; 2019 Jun; 58():1-8. PubMed ID: 30711634
[TBL] [Abstract][Full Text] [Related]
19. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway.
Zhang X; Guo Y; Xu X; Tang T; Sun L; Wang H; Zhou W; Fang L; Li Q; Xie P
Virus Res; 2019 Oct; 271():197671. PubMed ID: 31330207
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord.
Lu Y; Cao DL; Jiang BC; Yang T; Gao YJ
Brain Behav Immun; 2015 Oct; 49():119-29. PubMed ID: 25957028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
